P117 Axillary residual disease after neoadjuvant treatment according to disease burden in the sentinel lymph node biopsy

P117 Axillary residual disease after neoadjuvant treatment according to disease burden in the sentinel lymph node biopsy

Bibliographic Details
Main Authors:	L. López-Marín, S. Aragón, P. Zaragoza, L. Parrilla, M.C. Sanz, M. Gallego, M. Blanco, M.L. Arroyo, M. Ciaurriz
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623002345

Similar Items

P116 Axillary residual disease in patients with positive sentinel node after neoadjuvant treatment according to tumor subtype
by: L. López-Marín, et al.
Published: (2023-03-01)

P282 Survival outcomes after neoadjuvant chemotherapy according to the axillary status and tumor subtype
by: L. López-Marín, et al.
Published: (2023-03-01)

Sentinel Lymph Node Biopsy in Breast Cancer: Predictors of Axillary and Non-Sentinel Lymph Node Involvement
by: Hakan Postacı, et al.
Published: (2013-12-01)

The Accuracy of Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection in Breast Cancer
by: Abdolrasul Talei, et al.
Published: (2011-10-01)

Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
by: Khadidja Brahmi, et al.
Published: (2017-06-01)

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
by: Diane C. Ling, MD, et al.
Published: (2020-03-01)

Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
by: Toralf Reimer
Published: (2023-02-01)

Axillary sentinel lymph node biopsy after mastectomy: a case report
by: Hahm George, et al.
Published: (2010-07-01)

THE PREDICTIVE PROBABILITY OF TWO DIFFERENT BREAST CANCER NOMOGRAMS FOR NON SENTINEL AXILLARY LYMPH NODE METASTASIS IN POSITIVE SENTINEL LYMPH NODE BIOPSY
by: Akif Serhat Gür, et al.
Published: (2008-07-01)

Clinical impact of sentinel lymph node biopsy after neoadjuvant treatment in breast cancer patients with initially involved axillary lymph nodes; single-center experience- preliminary analysis
by: Ana Car-Peterko, et al.
Published: (2020-01-01)

Avoiding Axillary Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial
by: Toralf Reimer, et al.
Published: (2020-12-01)

Omitting axillary lymph node dissection in breast cancer patients with metastatic sentinel node after neoadjuvant chemotherapy
by: B. Kuru, et al.
Published: (2021-04-01)

Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer
by: Dalia Rukanskienė, et al.
Published: (2020-03-01)

Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
by: Capitanio Giovanni, et al.
Published: (2005-03-01)

Necessity of Low Partial Axillary Lymph Node Dissection for Breast Cancer Patients with Negative Result of Sentinel Lymph Node Biopsy
by: LIU Xuan, et al.
Published: (2018-12-01)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
by: Amparo Garcia-Tejedor, et al.
Published: (2023-08-01)

Will Radiomics Replace Sentinel Lymph Node Biopsy?
by: Abdullah S. Eldaly, et al.
Published: (2022-04-01)

Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy: Review of the Literature and Recommendations for Use in Patient Management
by: Yan Xing, et al.
Published: (2004-10-01)

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice
by: Sae Byul Lee, et al.
Published: (2019-01-01)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature
by: Alexandra Maria Lazar, et al.
Published: (2023-09-01)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
by: Hee Jun Choi, et al.
Published: (2022-11-01)

Axillary lymph node dissection could be omitted in the breast cancer patients with a limited sentinel lymph node involvement following neoadjuvant systemic treatment
by: Ana Car-Peterko, et al.
Published: (2021-01-01)

IS A COMPLETION AXILLARY DISSECTION NECESSARY FOR PATIENTS WITH METATASIS IN SENTINEL LYMPH NODE?
by: V. Özmen, et al.
Published: (2005-01-01)

Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy
by: Jing Si, et al.
Published: (2022-04-01)

After neoadjuvant therapy, axillary sentinel lymph node frozen sections from breast cancer patients are accurately diagnosed using telepathology
by: Valarie McMurtry, et al.
Published: (2022-01-01)

Sentinel lymph node biopsy in elderly breast cancer
by: Faccin L, et al.
Published: (2010-05-01)

Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma
by: Paulina Chmiel, et al.
Published: (2024-01-01)

Localization of metastasis within the sentinel lymph node biopsies: a predictor of additional axillary spread of breast cancer?
by: César Augusto Alvarenga, et al.
Published: (2013-11-01)

Preoperative Axillary Ultrasound-guided Wire Localization and lymphoscintigraphy for Sentinel Lymph Node Biopsy in Breast Cancer Patients
by: Fezzeh Elyasinia, et al.
Published: (2021-05-01)

Efficacy of pre - operative axillary ultrasonography in excluding nodal disease – can it replace sentinel lymph node biopsy in early stage breast cancer?
by: Nida Javed, et al.
Published: (2023-02-01)

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
by: Matilda Appelgren, et al.
Published: (2022-06-01)

Sentinel lymph node biopsy and neoadjuvant chemotherapy in the management of early breast cancer: Safety considerations and timing
by: Jenny Edge, et al.
Published: (2017-06-01)

Sentinel lymph node biopsy in breast cancer
by: Volkan Genç, et al.
Published: (2008-01-01)

Sentinel lymph node biopsy in breast neoplasms
by: Višnjić Milan, et al.
Published: (2009-01-01)

Sentinel Lymph Node Biopsy – Here to Stay
by: Louis W.C. Chow
Published: (2004-10-01)

EVALUATION OF SAFETY AND EFFICACY OF THE SENTINEL LYMPH NODE BIOPSY IN PATIENTS WITH EARLY-STAGE BREAST CANCER WITHOUT AXILLARY INVOLVEMENT
by: Orcun Yalav, et al.
Published: (2013-01-01)

Contraindications of sentinel lymph node biopsy: Áre there any really?
by: Zografos George, et al.
Published: (2007-01-01)

Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patients
by: Siyang Cao, et al.
Published: (2021-10-01)

Contemporary use of sentinel lymph node biopsy in the head and neck
by: Nolan B. Seim, et al.
Published: (2016-06-01)

Factors affecting sentinel lymph node metastasis in patients with breast cancer undergoing sentinel lymph node biopsy before or after systemic therapy
by: M.F. Sağdıç, et al.
Published: (2021-04-01)